Plain-English translation of NCT04735172 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are using a special type of brain imaging called 7-Tesla MRI to look at chemical differences in specific brain regions between people who were recently diagnosed with Parkinson's disease and healthy control subjects. This is a basic science study designed to help scientists understand what happens in the brain early in Parkinson's disease, before patients start medication treatment. The goal is to identify biological markers that might help doctors better understand and eventually treat the condition.
Early detection and better understanding of Parkinson's disease could lead to earlier treatment and better outcomes for patients. This study aims to find measurable differences in brain chemistry that occur in the earliest stages of the disease, which could eventually help doctors diagnose and manage Parkinson's more effectively.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have one visit at a hospital radiology department where you'll spend about 1 hour total. During this visit, researchers will assess your Parkinson's symptoms using standard clinical rating scales (about 30 minutes), and then you'll undergo a 7-Tesla MRI brain scan (about 30 minutes) that creates detailed images and measures chemical activity in specific brain regions. The MRI itself is a non-invasive imaging procedure where you lie still inside a scanning machine while it takes pictures of your brain — no injections, radiation, or medications are involved.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
France